Stock GLMD GALMED PHARMACEUTICALS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Galmed Pharmaceuticals Ltd.

Equities

GLMD

IL0011313900

Market Closed - Nasdaq
Other stock markets
 03:56:06 2024-05-23 pm EDT 		5-day change 1st Jan Change
0.39 USD -1.89% Intraday chart for Galmed Pharmaceuticals Ltd. -2.26% -14.29%
Apr. 04 Galmed Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 15 Galmed Pharmaceuticals Ltd. Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of Nash and Liver Fibrosis CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GLMD Stock
  4. News Galmed Pharmaceuticals Ltd.
  5. MarketScreener Editorial Features